Purdue Pharma (Canada) appoints New VP, R&D

Dr. Tom Koutsavlis, MD, MSc, FRCPC, MBA

Dr. Tom Koutsavlis, MD, MSc, FRCPC, MBA

Dr. Tom Koutsavlis, MD, MSc, FRCPC, MBA, has joined Purdue Pharma (Canada) as Vice President, Research and Development. Koutsavlis brings to Purdue Pharma (Canada) more than 20 years of senior level experience within the academic, government and corporate healthcare sectors, including several research-based pharmaceutical companies. Koutsavlis is an Epidemiologist and holds a Community Medicine Fellowship with the Royal College of Physicians and Surgeons of Canada.

"After knowing Tom for over two years, I know he has the experience, strong leadership skills, business acumen and passion for helping patients needed to be successful in this role," said Dr. Craig Landau, President and CEO, Purdue Pharma (Canada). "We look forward to Tom's energy and expertise as we continue to advance our fully integrated R&D capability and leverage our discovery and development partnerships."

As Vice President, Research and Development, Koutsavlis is responsible for the external R&D strategy, and the management of all current and future plans involving our Pharmaceutics, Analytics, Clinical Development, Medical and Regulatory Affairs functions.

Most recently, Koutsavlis's experience includes Vice President roles in both International and United States Medical Affairs at Shire and Senior Director leadership of Global Clinical Epidemiology at Abbott Laboratories. Tom has also held positions in the Montreal Regional Public Health Directorate and is currently an Adjunct Professor in the Department of Epidemiology, Biostatistics and Occupational Health, in the Faculty of Medicine at McGill University. He earned a Master of Science and a Doctor of Medicine from McGill. He is both a Quebec College and Royal College certified specialist physician in Public Health & Community Medicine, and received his Master of Business Administration from the John Molson School of Business. Koutsavlis sits on numerous corporate, philanthropic and community boards.

  • <<
  • >>

Join the Discussion